ZyVersa Therapeutics Earnings Estimates, EPS & Revenue | OTC:ZVSA

Comments

ZyVersa Therapeutics Inc Earnings Estimates

ZVSAOTCQB

Trade with Public

$0.3113

At close: Jul 25, 5:00 PM EST

Overview NewsEarningsAnalyst Ratings Short Interest

ZyVersa Therapeutics Earnings Estimates, EPS & Revenue | OTC:ZVSA

ZyVersa Therapeutics (ZVSA) is scheduled to report Q1 earnings on May 11, 2026.

ZyVersa Therapeutics has beaten EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, ZyVersa Therapeutics has averaged an EPS surprise of 0.30% and a revenue surprise of 0.00%.

Earnings Date

Nov 19

EPS

$-2.560

Quarterly Revenue

$0.00

Annual Revenue
(as of Sep 30)

–

ZyVersa Therapeutics Earnings History

Analyze the earnings history of ZyVersa Therapeutics using advanced sorting and filters.

ZyVersa Therapeutics (ZVSA) Earnings Per Share

The chart below shows ZyVersa Therapeutics's reported EPS compared to analyst estimates over recent quarters.

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q4	2025-03-27	$-1.31	$-2.73	52.0 %
Q3	2024-11-14	$-2.43	$-3.70	34.3 %
Q2	2024-08-09	$-3.31	$-3.75	11.7 %
Q1	2024-05-15	$-4.53	$-3.70	-22.4 %

ZyVersa Therapeutics (ZVSA) Revenue

The chart below shows ZyVersa Therapeutics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is ZyVersa Therapeutics (OTCQB:ZVSA) reporting earnings?

ZyVersa Therapeutics (ZVSA) is scheduled to report earnings on May 11, 2026. The last reported earnings were for reported on November 19, 2025 for Q3.

What were the latest earnings per share (EPS) for ZyVersa Therapeutics (OTCQB:ZVSA)?

The Actual EPS was $-2.56, which missed the estimate of $0.00.

What were ZyVersa Therapeutics’s (OTCQB:ZVSA) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

ZyVersa Therapeutics Earnings Estimates, EPS & Revenue | OTC:ZVSA

ZyVersa Therapeutics (ZVSA) is scheduled to report Q1 earnings on May 11, 2026.

ZyVersa Therapeutics has beaten EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, ZyVersa Therapeutics has averaged an EPS surprise of 0.30% and a revenue surprise of 0.00%.

Earnings Date

Nov 19

EPS

$-2.560

Quarterly Revenue

$0.00

Annual Revenue
(as of Sep 30)

–